KDM3A directly upregulates the expression of krüppel-like factor 2 (KLF2) and interferon regulatory factor 4(IRF4), which are essential transcription factors for MM cell survival, by removing H3K9me1/me2 from their promoters. The gene discussed is KDM3A; the disease is Miyoshi myopathy.